There are 2773 resources available
208P - ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
Presenter: Peter Schmid
Session: ePoster Display
475P - A phase Ib study of NUC-3373, a targeted inhibitor of thymidylate synthase, in combination with standard therapies in patients with advanced colorectal cancer (NuTide:302)
Presenter: Jordan Berlin
Session: ePoster Display
309P - Antineoplastic (ANP) therapies (Tx) after alpelisib (ALP) or placebo (PBO) + fulvestrant (FUL) in patients (Pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA-mutated (Mut) advanced breast cancer (ABC): An analysis from SOLAR-1
Presenter: Fabrice André
Session: ePoster Display
372P - The prognostic value of liver metastases and how affects the applicability of the lung-molGPA in non-small cell lung cancer patients with brain metastases
Presenter: Joel Rafael Veas Rodriguez
Session: ePoster Display
480P - Gene expression of NANOG and NANOGP8 in colorectal cancer
Presenter: Hiroyuki Arai
Session: ePoster Display
374P - A real-world application of aqueous humor and vitreous fluid for the diagnosis of vitreoretinal lymphoma and treatment monitoring
Presenter: Xiaoxiao Wang
Session: ePoster Display
483P - The correlation analysis between MUC16 mutation and immunotherapy predictive biomarkers in colon adenocarcinoma
Presenter: Gong Chen
Session: ePoster Display
377P - Comparison of current guidelines and real-world evidence data for the treatment of glioblastoma across Europe
Presenter: Carrmen Escorial
Session: ePoster Display
487P - Targeting PDL-1 in colon cancer using nuclear receptor 4A1 (NR41) antagonist
Presenter: Maen Abdelrahim
Session: ePoster Display
154P - Five-year follow-up of the phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in patients with HER2 positive early or locally advanced breast cancer
Presenter: Xavier Pivot
Session: ePoster Display